Tags

Type your tag names separated by a space and hit enter

Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy.

Abstract

Patients with and without adverse reactions on practolol therapy showed altered immune responses. There was cutaneous anergy to Candida albicans and streptokinase/streptodornase antigens and depression of lymphocyte function in vitro. Anticomplementary activity and a wide range of autoantibodies were found in patients who had received practolol.

Links

  • Publisher Full Text
  • Authors

    , , ,

    Source

    Lancet (London, England) 2:7993 1976 Nov 06 pg 984-7

    MeSH

    Adult
    Aged
    Autoantibodies
    Autoimmune Diseases
    Coronary Disease
    Drug Eruptions
    Eye Diseases
    Female
    Humans
    Immunologic Techniques
    Leukocytes
    Male
    Middle Aged
    Practolol
    Syndrome

    Pub Type(s)

    Journal Article

    Language

    eng

    PubMed ID

    62263

    Citation

    Behan, P O., et al. "Immunological Abnormalities in Patients Who Had the Oculomucocutaneous Syndrome Associated With Practolol Therapy." Lancet (London, England), vol. 2, no. 7993, 1976, pp. 984-7.
    Behan PO, Behan WM, Zacharias FJ, et al. Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy. Lancet. 1976;2(7993):984-7.
    Behan, P. O., Behan, W. M., Zacharias, F. J., & Nicholls, J. T. (1976). Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy. Lancet (London, England), 2(7993), pp. 984-7.
    Behan PO, et al. Immunological Abnormalities in Patients Who Had the Oculomucocutaneous Syndrome Associated With Practolol Therapy. Lancet. 1976 Nov 6;2(7993):984-7. PubMed PMID: 62263.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy. AU - Behan,P O, AU - Behan,W M, AU - Zacharias,F J, AU - Nicholls,J T, PY - 1976/11/6/pubmed PY - 1976/11/6/medline PY - 1976/11/6/entrez SP - 984 EP - 7 JF - Lancet (London, England) JO - Lancet VL - 2 IS - 7993 N2 - Patients with and without adverse reactions on practolol therapy showed altered immune responses. There was cutaneous anergy to Candida albicans and streptokinase/streptodornase antigens and depression of lymphocyte function in vitro. Anticomplementary activity and a wide range of autoantibodies were found in patients who had received practolol. SN - 0140-6736 UR - https://www.unboundmedicine.com/medline/citation/62263/Immunological_abnormalities_in_patients_who_had_the_oculomucocutaneous_syndrome_associated_with_practolol_therapy_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(76)90831-X DB - PRIME DP - Unbound Medicine ER -